Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2845
-0.0105 (-3.56%)
At close: Mar 24, 2026, 4:00 PM EDT
0.2821
-0.0024 (-0.84%)
After-hours: Mar 24, 2026, 4:49 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.04 million as of March 24, 2026. Its market cap has decreased by -91.88% in one year.
Market Cap
2.04M
Enterprise Value
-5.05M
1-Year Change
-91.88%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.04M, a decrease of -99.26%. That is a compound annual growth rate of -67.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.11M | -63.66% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioRestorative Therapies | 2.48M |
| HCW Biologics | 2.42M |
| Scinai Immunotherapeutics | 2.23M |
| Onconetix | 2.22M |
| Bone Biologics | 2.08M |
| Ensysce Biosciences | 2.07M |
| 60 Degrees Pharmaceuticals | 2.06M |
| KALA BIO | 1.94M |